Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0288 | 0.8293 | 0.8293 |
Loa Loa (eye worm) | guanylyl cyclase/natriuretic peptide receptor | 0.0328 | 1 | 1 |
Echinococcus multilocularis | atrial natriuretic peptide receptor 1 | 0.0098 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0328 | 1 | 1 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0328 | 1 | 1 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0288 | 0.8293 | 0.8293 |
Onchocerca volvulus | 0.0328 | 1 | 0.5 | |
Schistosoma mansoni | soluble guanylyl cyclase beta-3 | 0.0273 | 0.7627 | 0.7627 |
Schistosoma mansoni | hypothetical protein | 0.0273 | 0.7627 | 0.7627 |
Echinococcus granulosus | atrial natriuretic peptide receptor 1 | 0.0098 | 0 | 0.5 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0288 | 0.8293 | 0.8293 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.